Shin Seung-Ho, Piazza Paolo, De Donato Giuseppe, Sivalingam Shailendra, Lauda Lorenzo, Vitullo Francesca, Sanna Mario
Department of Otolaryngology-Head and Neck Surgery, CHA University, Seongnam, Republic of Korea.
Audiol Neurootol. 2012;17(1):39-53. doi: 10.1159/000329213. Epub 2011 Jun 17.
The primary treatment of vagal paraganglioma (VP) includes 'wait and scan', surgery and radiotherapy.
To present the clinical findings, surgical treatment including application of internal carotid artery (ICA) stenting to facilitate surgery, and complications, as well as to review the literature and to discuss the decision-making process in the management of VP cases based on our experience and the literature.
A retrospective case review of 22 cases with VP.
Quaternary neurotologic and skull base referral center.
The retrospective chart review identified 22 patients presenting with VP. Our indication for surgery was VP in younger patients, irrespective of the existence of vocal cord paralysis. Preoperative endovascular management of the ICA included permanent balloon occlusion (PBO) and stenting. The transcervical approach and the infratemporal fossa approach type A (ITFA) were used.
Fifteen cases had multicentric paragangliomas, 5 cases bilateral tumors, 3 cases a genetic mutation, and 2 cases a positive family history. The most common symptoms were hoarseness, tinnitus and hearing loss. The surgical approaches commonly employed for excision were the transcervical approach (9 cases) and the ITFA (12 cases), whereas 1 case did not have surgery. Three cases had PBO and 7 had intracarotid stent insertion. Gross total removal was achieved in 19 cases, and 1 case had a recurrence. Eighteen cases had no dysphagia or were well compensated after surgery. There were no significant complications noted in our series.
In younger patients with VP, surgery should be recommended. The proper preoperative endovascular intervention and surgical approach facilitates gross total tumor removal. In the management of bilateral or familial paragangliomas, careful and appropriate decision making is essential.
迷走神经副神经节瘤(VP)的主要治疗方法包括“观察与扫描”、手术和放疗。
介绍临床发现、包括应用颈内动脉(ICA)支架置入术辅助手术的手术治疗方法及并发症,回顾文献,并根据我们的经验和文献讨论VP病例管理中的决策过程。
对22例VP病例进行回顾性病例分析。
四级神经耳科和颅底转诊中心。
通过回顾性病历审查确定22例VP患者。我们的手术指征是年轻患者的VP,无论是否存在声带麻痹。ICA的术前血管内治疗包括永久性球囊闭塞(PBO)和支架置入术。采用经颈入路和A型颞下窝入路(ITFA)。
15例有多发性副神经节瘤,5例为双侧肿瘤,3例有基因突变,2例有家族史阳性。最常见的症状是声音嘶哑、耳鸣和听力丧失。切除常用的手术入路是经颈入路(9例)和ITFA(12例),而1例未进行手术。3例进行了PBO,7例进行了颈内动脉支架置入。19例实现了肿瘤全切,1例复发。18例术后无吞咽困难或得到良好代偿。我们的系列研究中未发现明显并发症。
对于年轻的VP患者,应推荐手术治疗。适当的术前血管内干预和手术入路有助于实现肿瘤全切。在双侧或家族性副神经节瘤的管理中,谨慎且恰当的决策至关重要。